Tohoku J. Exp. Med., 2006, 208(4)

Case Report

Serum Antibody Against Granulocyte/Macrophage Colony-Stimulating Factor and KL-6 in Idiopathic Pulmonary Alveolar Proteinosis

MASAYUKI NARA, KUNIO SANO, HIROMASA OGAWA, TSUTOMU TAMADA, MIYUKI NAGAOKA, KATSUNORI OKADA,1 MIKA WATANABE,2 TAKUYA MORIYA,2 HIROSHI MIKI,3 KOH NAKATA,4 MASAKAZU ICHINOSE5 and TOSHIO HATTORI

Department of Infectious and Respiratory Diseases, 1Department of Respiratory Surgery, 2Department of Pathology, Tohoku University School of Medicine, Sendai, Japan, 3Sendai Medical Center, Sendai, Japan, 4Bioscience Medical Research Center, Niigata University, Niigata, Japan, 5The Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan

Here we describe a case of idiopathic pulmonary alveolar proteinosis (I-PAP), in which anti-granulocyte/macrophage colony-stimulating factor (GM-CSF) antibody and high level of KL-6 were found in the serum. Anti-GM-CSF antibody is responsible for I-PAP, and KL-6 is a serum marker for the activity of diffuse interstitial lung disease. A 38-year-old woman, who had no symptoms, was found to have an abnormal shadow on chest radiograph 5 years previously at a health check up. Chest radiograph showed a patchy shadow in the left lower lung field. Thoracoscopic biopsy was performed because the shadow had gradually expanded during the 5 years. Histological examination revealed proteinous material filling the alveoli and positive staining by the PAS method, suggesting PAP. Anti-GM-CSF antibody and a high level of KL-6 were detected in the serum at the time of diagnosis. Three years later, the shadow disappeared spontaneously. During this period, the level of KL-6 dramatically decreased, although that of GM-CSF antibody remained unchanged. The present case suggests that the serum level of the anti-GM-CSF antibody represents a useful marker for the diagnosis but not for follow-up of the clinical course. On the contrary, KL-6 is an excellent marker for the assessment of the clinical course of I-PAP.

keywords —— GM-CSF; proteinous material; autoimmune disease; thoracoscopic biopsy

===============================

Tohoku J. Exp. Med., 2006, 208, 349-354

Correspondence: Masayuki Nara, M.D., Ph.D., Division of Infectious and Respiratory Diseases, Department of Internal Medicine, Tohoku University School of Medicine, 1-1 Seiryomachi, Aoba-ku, Sendai 980-8574, Japan.

e-mail: nara@rid.med.tohoku.ac.jp